Source: Global University Venturing

Immetas: Immetas measures up to $11m - Global University Venturing

Morningside has thrown its weight behind the Harvard spinout, which is developing antibodies to treat cancer and inflammatory diseases.

Read full article »
Immetas's Competitors | Immetas's News | Immetas's Financials
Stay up-to-date with the latest news on Immetas
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
J. Gene Wang's photo - Co-Founder & CEO of Immetas

Co-Founder & CEO

J. Gene Wang

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Immetas